| CSVAX | TROZX | CSVAX / TROZX | |
| Total Expense Ratio | 1.20 | 0.00 | - |
| Annual Report Gross Expense Ratio | 1.28 | 0.65 | 197% |
| Fund Existence | 24 years | 6 years | - |
| Gain YTD | 19.522 | 18.586 | 105% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 2000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 707M | 17.4B | 4% |
| Annual Yield % from dividends | 2.28 | 2.83 | 80% |
| Returns for 1 year | 30.90 | 32.17 | 96% |
| Returns for 3 years | 58.59 | 97.26 | 60% |
| Returns for 5 years | 43.35 | 109.11 | 40% |
| Returns for 10 years | 87.93 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| LHCTX | 24.44 | 0.57 | +2.39% |
| Lord Abbett Health Care R5 | |||
| ETIHX | 59.59 | 0.77 | +1.31% |
| Eventide Healthcare & Life Sciences I | |||
| AWPAX | 22.51 | 0.19 | +0.85% |
| AB Sustainable Intl Thematic A | |||
| APHHX | 25.23 | 0.13 | +0.52% |
| Artisan Global Equity Institutional | |||
| FDETX | 31.82 | 0.11 | +0.35% |
| Fidelity Advisor Capital Development O | |||